irreversible inhibition


Also found in: Encyclopedia.

irreversible inhibition

the action of an inhibitor such that, once bound to a protein, it cannot dissociate.
Farlex Partner Medical Dictionary © Farlex 2012
References in periodicals archive ?
Irreversible inhibition therefore requires the formation of new enzyme for prostaglandin synthesis.
Ref: 'Irreversible inhibition of cytosolic thioredoxin reductase 1 as a mechanistic basis for anticancer therapy'.
These interactions are formed rapidly and can be easily removed; hence, the enzyme and inhibitor complex are quickly dissociated opposite to irreversible inhibition. Due to reversible binding ability to biomolecules, such inhibitors carry a lower risk of side effects compared to irreversible inhibitors.
Although the mechanism of cardiac toxicities of ibrutinib remains uncertain, it is possible that this at least in part may be due to irreversible inhibition of certain protective tyrosine kinases which may have a key role in cardiac function and electrophysiological properties.
(9) Unlike the irreversible inhibition of CYP3A4 by furanocoumarins, flavanoids effects on OATPs have been shown to decrease within 4 hours.
We then extended our studies to a cytosolic protein, glutathione Stransferase (GST), and observed that incubation of PA along with TAase resulted in the irreversible inhibition of GST and this evidence has served as an elegant assay method for TAase [12] (Figure 1).
An assay procedure for TAase was developed based on the irreversible inhibition of Glutathione-S-transferase (GST) by PA, the extent of inhibition of GST was considered proportional to the activity of TAase.
KEY WORDS: aromatic amine carcinogens, arylamine N-acetyltransferases, cadmium, irreversible inhibition, xenobiotic metabolism.
Avila Therapeutics Inc., a biotechnology company developing novel targeted covalent drugs, has demonstrated the first-ever selective irreversible inhibition of a viral protease using a targeted covalent drug.
Catalytic irreversible inhibition of Trypanossomo brucei ornithine decarboxylase (E.C.4.1.1.17) by substrate and product analogs and effects on murine trypoasomiasis.